Mayer Brown advises Avedon on the acquisition of a shareholding in FormMed HealthCare AG

Mayer Brown has advised Avedon Capital Partners ("Avedon") on the acquisition of a shareholding in FormMed HealthCare AG (“FormMed”).

FormMed is a leading developer and supplier of micronutrition for therapeutic use based in Frankfurt am Main, Germany. In partnership with Avedon, FormMed seeks to accelerate growth in its core market Germany and further internationalize to selected European core markets. This includes a further granularization of the product portfolio, investments into organizational build-up and selected distribution partners.

Avedon Capital Partners is a leading private equity fund manager in Germany, focusing on high-growth, mid-sized companies in Germany and the Benelux countries. Avedon manages assets with a value of more than €600 million. Mayer Brown has successfully advised Avedon for several years, including, for example, on the acquisition of Hauck Group in a combined share and asset deal in Germany and Hong Kong.

The Mayer Brown team was led by Corporate & Securities partner Carsten Flaßhoff (Düsseldorf) and included: Corporate & Securities — partner Dr. Jan Streer (Düsseldorf), counsel Dr. Tobias Reiser (Frankfurt), senior associate Simon W. Tissen, associates Wolfgang Löffler (Düsseldorf) and Inga Rupp (Frankfurt); Banking & Finance — partner Dr. Martin Heuber, counsel Odilo Wallner, and associates Max Birk and Merve Schmitte (all Frankfurt); Employment & Benefits — counsel Björn Vollmuth (Frankfurt); Real Estate — associate Maik Sebastian Lammers (Düsseldorf); Intellectual Property — partner Christoph J. Crützen and associate Maximilian Kücking (both Düsseldorf); and Antitrust & Competition — partner Christian Horstkotte and senior associate Matthias Jannausch (both Düsseldorf).